David Arterburn to Risk Assessment
This is a "connection" page, showing publications David Arterburn has written about Risk Assessment.
Connection Strength
0.451
-
Decision aids for benign prostatic hyperplasia and prostate cancer. Am J Manag Care. 2015 Feb 01; 21(2):e130-40.
Score: 0.089
-
Predicting 90-day mortality after bariatric surgery: an independent, external validation of the OS-MRS prognostic risk score. Surg Obes Relat Dis. 2014 Sep-Oct; 10(5):774-9.
Score: 0.084
-
A population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes. Surg Obes Relat Dis. 2013 Nov-Dec; 9(6):837-44.
Score: 0.079
-
Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009 Feb; 19(2):184-189.
Score: 0.057
-
Interventions and Operations 5 Years After Bariatric Surgery in a Cohort From the US National Patient-Centered Clinical Research Network Bariatric Study. JAMA Surg. 2020 03 01; 155(3):194-204.
Score: 0.032
-
Risk of Operative and Nonoperative Interventions Up to 4 Years After Roux-en-Y Gastric Bypass vs Vertical Sleeve Gastrectomy in a Nationwide US Commercial Insurance Claims Database. JAMA Netw Open. 2019 12 02; 2(12):e1917603.
Score: 0.031
-
Metabolic Syndrome in Adults With Congenital Heart Disease. J Am Heart Assoc. 2016 Feb 12; 5(2).
Score: 0.024
-
Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg. 2015 May; 261(5):914-9.
Score: 0.023
-
Obesity, depression, and health services costs among middle-aged women. J Gen Intern Med. 2011 Nov; 26(11):1284-90.
Score: 0.017
-
Decision modeling to estimate the impact of gastric bypass surgery on life expectancy for the treatment of morbid obesity. Arch Surg. 2010 Jan; 145(1):57-62.
Score: 0.016